Literature DB >> 16973664

Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey.

Andrea Sodi1, Alexander S Ioannidis, Atul Mehta, Clare Davey, Michael Beck, Suzanne Pitz.   

Abstract

BACKGROUND: Fabry's disease is an X-linked lysosomal storage disorder characterised by deficient activity of the enzyme alpha-galactosidase A. AIM: To study eye abnormalities in patients with Fabry's disease in the Fabry Outcome Survey (FOS).
METHODS: This is the largest study of ocular manifestations in patients with Fabry's disease. In all, 173 of the 688 patients enrolled in FOS underwent a detailed ophthalmic examination, with a special focus on abnormalities of the cornea, lens, conjunctival and retinal vessels.
RESULTS: Cornea verticillata was reported in 76.9% of females and 73.1% of males; vessel tortuosity was observed in 21.9% of females and in 48.7% of males. Fabry cataract was recorded in 9.8% of females and in 23.1% of males. Cornea verticillata was therefore the most frequently reported ophthalmic abnormality in Fabry's disease in both hemizygotic males and heterozygotic females. Tortuous conjunctival and retinal vessels and Fabry cataract were more frequently found in males than in females. Vessel tortuosity was more frequently observed in patients with a higher severity score and greater impairment of renal and cardiac function, suggesting that it may be associated with a more severe disease. The youngest patient with ocular changes was 3 years old. The prevalence of tortuous vessels in males increased with age.
CONCLUSION: The presence of cornea verticillata is a useful aid in the diagnosis of Fabry's disease, as it is often present at the time of diagnosis. Vessel tortuosity may have some predictive value for systemic involvement.

Entities:  

Mesh:

Year:  2006        PMID: 16973664      PMCID: PMC1857640          DOI: 10.1136/bjo.2006.100602

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  25 in total

1.  Estrogen-replacement therapy: effects on retrobulbar hemodynamics.

Authors:  M Harris-Yitzhak; A Harris; Z Ben-Refael; D Zarfati; H J Garzozi; B J Martin
Journal:  Am J Ophthalmol       Date:  2000-05       Impact factor: 5.258

Review 2.  Vascular complications of Fabry disease: enzyme replacement and other therapies.

Authors:  D A Hughes; A B Mehta
Journal:  Acta Paediatr Suppl       Date:  2005-03

3.  Histopathologic findings of cornea verticillata in a woman heterozygous for Fabry's disease.

Authors:  K Hirano; K Murata; A Miyagawa; H Terasaki; J Saigusa; T Nagasaka; M Kobayashi
Journal:  Cornea       Date:  2001-03       Impact factor: 2.651

4.  Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre.

Authors:  Thanh T Nguyen; Trevor Gin; Kathy Nicholls; Michael Low; Jason Galanos; Andrew Crawford
Journal:  Clin Exp Ophthalmol       Date:  2005-04       Impact factor: 4.207

Review 5.  Advances in the management of Anderson-Fabry disease: enzyme replacement therapy.

Authors:  Gregory M Pastores; Ravi Thadhani
Journal:  Expert Opin Biol Ther       Date:  2002-03       Impact factor: 4.388

6.  Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients.

Authors:  Christophe Orssaud; Jean Dufier; Dominique Germain
Journal:  Ophthalmic Genet       Date:  2003-09       Impact factor: 1.803

Review 7.  [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].

Authors:  Dominique P Germain
Journal:  J Soc Biol       Date:  2002

8.  Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey.

Authors:  Uma Ramaswami; Catharina Whybra; Rosella Parini; Guillem Pintos-Morell; Atul Mehta; Gere Sunder-Plassmann; Urs Widmer; Michael Beck
Journal:  Acta Paediatr       Date:  2006-01       Impact factor: 2.299

9.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

Authors:  A Mehta; R Ricci; U Widmer; F Dehout; A Garcia de Lorenzo; C Kampmann; A Linhart; G Sunder-Plassmann; M Ries; M Beck
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

10.  The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.

Authors:  C Whybra; C Kampmann; F Krummenauer; M Ries; E Mengel; E Miebach; F Baehner; K Kim; M Bajbouj; A Schwarting; A Gal; M Beck
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  33 in total

1.  Vascular tortuosity: a mathematical modeling perspective.

Authors:  Leith Hathout; Huy M Do
Journal:  J Physiol Sci       Date:  2012-01-18       Impact factor: 2.781

Review 2.  Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.

Authors:  Hui Chen; Annie Y Chan; Donald U Stone; Nawajes A Mandal
Journal:  Surv Ophthalmol       Date:  2013-09-05       Impact factor: 6.048

3.  Cilioretinal artery occlusion and anterior ischemic optic neuropathy as the initial presentation in a child female carrier of Fabry disease.

Authors:  M Giray Ersoz; Gamze Ture
Journal:  Int Ophthalmol       Date:  2017-03-09       Impact factor: 2.031

4.  Assessment of corneal topographic, tomographic, densitometric, and biomechanical properties of Fabry patients with ocular manifestations.

Authors:  Veysel Cankurtaran; Kemal Tekin; Ayse Idil Cakmak; Merve Inanc; Faruk Hilmi Turgut
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-08       Impact factor: 3.117

5.  Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease.

Authors:  D Marchesan; T M Cox; P B Deegan
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

6.  Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A).

Authors:  Hsiang-Yu Lin; Cheng-Hung Huang; Hsiao-Chi Yu; Kah-Wai Chong; Ju-Hui Hsu; Pi-Chang Lee; Kang-Hsiang Cheng; Chuan-Chi Chiang; Huey-Jane Ho; Shuan-Pei Lin; Shih-Jen Chen; Po-Kang Lin; Dau-Ming Niu
Journal:  J Inherit Metab Dis       Date:  2010-09-07       Impact factor: 4.982

Review 7.  Fabry disease-often seen, rarely diagnosed.

Authors:  Björn Hoffmann; Ertan Mayatepek
Journal:  Dtsch Arztebl Int       Date:  2009-06-26       Impact factor: 5.594

Review 8.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

9.  The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study.

Authors:  Karen Falke; Armin Büttner; Michael Schittkowski; Oliver Stachs; Robert Kraak; Andrey Zhivov; Arndt Rolfs; Rudolf Guthoff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-18       Impact factor: 3.117

10.  Eye features in three Danish patients with multisystemic smooth muscle dysfunction syndrome.

Authors:  Hans Ulrik Moller; Hans C Fledelius; Dianna M Milewicz; Ellen S Regalado; John R Ostergaard
Journal:  Br J Ophthalmol       Date:  2012-07-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.